Tools   Select Another Resource Report Type

http://vassarstats.net/

Tools for performing statistical computation including: Clinical Research Calculators Probabilities Distributions Frequency Data Proportions Ordinal Data Correlation & Regression t-Tests & Procedures ANOVA ANCOVA

Proper citation: VassarStats (RRID:SCR_010263) Copy   

•   Source: SciCrunch Registry

http://bioen-compbio.bioen.illinois.edu/TrueSight/

Self-training Algorithm for Splice Junction Detection using RNA-seq.

Proper citation: TrueSight (RRID:SCR_009835) Copy   

•   Source: SciCrunch Registry

http://www.rcsi.ie/

Private university responsible for the medical speciality of surgery throughout Ireland.

Proper citation: Royal College of Surgeons in Ireland; Dublin; Ireland (RRID:SCR_009786) Copy   

•   Source: SciCrunch Registry

http://www.kti.admin.ch/index.html?lang=en

Proper citation: Swiss Commission for Technology and Innovation (RRID:SCR_010084) Copy   

•   Source: SciCrunch Registry

http://compbio.dfci.harvard.edu/

A computational biology laboratory that builds and redistributes genetic software tools.

Proper citation: Computational Biology and Functional Genomics Laboratory at Harvard (RRID:SCR_010240) Copy   

•   Source: SciCrunch Registry

http://hkbic.cuhk.edu.hk/software/abmapper

A portable, easy-to-use package for spliced alignment, junction site detection, and reads mapping. The core module was written in C++ and wrapped in PERL scripts.

Proper citation: ABMapper (RRID:SCR_010242) Copy   

•   Source: SciCrunch Registry

http://www.ucsf.edu/

Public research university in San Francisco, California. Part of University of California system. Dedicated entirely to health sciences. Major center of medical and biological research and teaching. Ranked as one of top universities in biomedical field in USA and around world.

Proper citation: University of California at San Francisco; California; USA (RRID:SCR_010605) Copy   

•   Source: SciCrunch Registry

http://htsvipr.sourceforge.net/

A software program to screen for sequence variants (SNPs, deletions) in sequence data generated by high-throughput-sequencing platforms.

Proper citation: vipR (RRID:SCR_010685) Copy   

•   Source: SciCrunch Registry

http://www.genome.umd.edu/masurca.html

A whole genome assembly software that combines the efficiency of the de Bruijn graph and Overlap-Layout-Consensus (OLC) approaches., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: MaSuRCA (RRID:SCR_010691) Copy   

•   Source: SciCrunch Registry

http://www.lifeextensionfoundation.org/

Established in 1980, the Life Extension Foundation is a nonprofit organization, whose long-range goal is to radically extend the healthy human lifespan by discovering scientific methods to control aging and eradicate disease. The largest organization of its kind in the world, the Life Extension Foundation has always been at the forefront of discovering new scientific breakthroughs for use in developing novel disease prevention and treatment protocols to improve the quality and length of human life. Through its private funding of research programs aimed at identifying and developing new therapies to slow and even reverse the aging process, the Life Extension Foundation seeks to reduce, and ultimately eliminate, such age-related killers as heart disease, stroke, cancer and Alzheimer''s disease. Long-time members are keenly aware of the scientific research that Life Extension Foundation funds to develop validated methods to slow and reverse the aging process. Less known is Life Extension''s multi-prong program to develop safer and more effective cancer therapies. One reason we focus so heavily on cancer research is that this dreaded disease represents a roadblock in our ability to develop effective means to combat aging.

Proper citation: Life Extension Foundation (RRID:SCR_010574) Copy   

•   Source: SciCrunch Registry

http://bioinformatics.research.nicta.com.au/software/gossamer/

A software application for the de novo assembly of genomes from fragments of DNA that specifically attacks the question of scalability.

Proper citation: Gossamer (RRID:SCR_010612) Copy   

•   Source: SciCrunch Registry

http://neurolog.polytech.unice.fr/doku.php?id=neurolog

THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 16, 2013. The NeuroLOG consortium is addressing: *Management and access of partly structured data, heterogeneous and distributed in an open environment. *Access control and protection of private medical data. *Control of workflows implied in complex computing process on grid infrastructures. *Extraction and quantification of relevant parameters for different pathologies: Multiple sclerosis, Brain Vascular Stroke, Brain tumors Four application pipelines have been proposed in the context of the project. The pipelines are formalized using the Scufl data flow language. *Multiple Sclerosis image analysis pipelines *Brain Stroke application pipeline (from GIN) *Stroke / tumours Anacom application pipeline (from IFR49) Different softwares developed and/or used in this project are presented., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: NeuroLOG (RRID:SCR_010582) Copy   

•   Source: SciCrunch Registry

http://www.plosone.org/article/info:doi%2F10.1371%2Fjournal.pone.0023501

An algorithm for de novo genome assembly with short paired-end reads.

Proper citation: Meraculous (RRID:SCR_010700) Copy   

•   Source: SciCrunch Registry

http://bioinformatics.ubc.ca/matrix2png/

An open visualization tool for the display of matrix data. It is available for download or interactive web use. It is a simple but powerful program for making visualizations of microarray data and many other data types. It generates PNG formatted images from text files of data. It is fast, easy to use, and reasonably flexible. It can be used to generate publication-quality images, or to act as a image generator for web applications. Our group has found it useful for imaging all kinds of matrix-based data, not just microarray data.

Proper citation: Matrix2png (RRID:SCR_010669) Copy   

•   Source: SciCrunch Registry

http://www.barthsyndrome.org/english/view.asp?x=1

The Barth Syndrome Foundation, together with our affiliates, is a community of families, physicians, scientists, donors and volunteers around the world. As our mission statement says, we are dedicated to saving lives through education, advances in treatment, and finding a cure for Barth syndrome - a sometimes fatal, oftentimes debilitating genetic disease. Our work includes: * Raising awareness among physicians, scientists, and the general public; * Supporting relevant research through an international grant research program; * Providing a caring and educational community for affected families; and * Hosting a unique information resource. Working together we are making a difference in the lives of children and their families. One day there will be a cure; we hope you will help us make that day come sooner. We are the only world-wide volunteer organization dedicated to saving lives through education, advances in treatment and pursuit of a cure for Barth syndrome (BTHS). We started in 2000, after the first international conference held in Baltimore, MD (USA) where families from around the world met to discuss BTHS. As a result, we made a unanimous decision to work together to find a cure for this multi-system disorder. Our Foundation strives to accelerate progress through collaboration between families and scientists. We encourage family participation in research. Also, we provide several ways to keep up-to-date about advances in science and medicine. Our principal education event is our biennial international scientific, medical and family conference, which brings together the largest number of individuals interested in Barth syndrome. Our Family Services team is continually developing new informational resources in response to the needs of families, individuals, and professionals working with those affected by Barth syndrome.

Proper citation: Barth Syndrome Foundation (RRID:SCR_010556) Copy   

•   Source: SciCrunch Registry

http://www.allosource.org/

AlloSource is a non-profit organization founded in 1994 on a promise to honor and respect the gift of donation by responsibly developing, processing and distributing life-saving and life-enhancing allografts for our communities. Today, each of our 300 employees continues to fulfill this promise through multi-shift, 360-day processing to the highest quality and service standards. We strive to be the tissue network patients and the world''s most respected transplant teams ask for by name. This is accomplished by understanding the needs of our doctors and by providing the best tissue for our recipients. We offer more than 200 standard and customized precision allograft products, and act as a trusted and knowledgeable partner to the medical community, all with the intention of maximizing medical impact. In 1995, Allosource evolved from a local tissue bank in Denver, Colorado into a national organization serving communities around the country. Today, AlloSource is one of the largest, most respected tissue banks in the United States. Through our growth we''ve remained committed to the wishes of donor families, the needs of our surgeon customers, and the hopes of our patient recipients. Our promise of doing more with life reflects our unwavering focus on integrity, quality, safety, and respect today, and into the future.

Proper citation: AlloSource (RRID:SCR_010683) Copy   

•   Source: SciCrunch Registry

http://www.jacksonimmuno.com/

A commercial antibody vendor, specializing in secondary antibodies.

Proper citation: Jackson ImmunoResearch (RRID:SCR_010488) Copy   

•   Source: SciCrunch Registry

http://www.ctmm.nl/en/programmas/infrastructuren/traitprojecttranslationeleresearch

An ambitious project to develop an IT infrastructure for translational research that aims to facilitate the collection, storage, analysis, archiving, sharing and securing of data.

Proper citation: TraIT (RRID:SCR_010493) Copy   

•   Source: SciCrunch Registry

http://www.bio.ifi.lmu.de/contextmap

A context-based approach to identify the most likely mapping for RNA-seq experiments.

Proper citation: ContextMap (RRID:SCR_010496) Copy   

•   Source: SciCrunch Registry

http://www.alkermes.com/

A biopharmaceutical company that focuses on central nervous system (CNS) diseases. The company is the result of a merger between Alkermes, Inc. and Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Elan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts and manufacturing facilities in Athlone, Ireland; Gainesville, Georgia; and Wilmington, Ohio. Alkermes has more than 20 commercial drug products and candidates that address serious and chronic diseases such as addiction, schizophrenia, diabetes and depression. Among these, five products are primary to the company: risperidone Long-Acting Injection (Risperdal Consta) for schizophrenia and bipolar 1 disorder, paliperidone palmitate (Invega Sustenna in the U.S., Xeplion in Europe) for schizophrenia, 4-aminopyridine (Ampyra in the U.S., Fampyra in Europe) to improve walking in patients with multiple sclerosis, naltrexone for extended-release injectable suspension (Vivitrol) for alcohol and opioid dependence, and exenatide extended-release for injectable suspension (Bydureon) for the treatment of type 2 diabetes. Bydureon is a once-weekly, long-acting form of the drug exenatide (Byetta) and was developed through a partnership between Amylin, Alkermes and Eli Lilly. It is approved in Europe and the U.S. (Wikipedia)

Proper citation: Alkermes (RRID:SCR_010497) Copy   

•   Source: SciCrunch Registry